AstraZeneca

AstraZeneca DSCR

Debt Service Coverage Ratio (DSCR) of AstraZeneca (AZN) as of Oct 16, 2026.

DSCR

-

Last updated:

Debt Service Coverage Ratio (DSCR) of AstraZeneca is 2026 - . Debt Service Coverage Ratio (DSCR) of AstraZeneca was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

AstraZeneca Stock analysis

What does AstraZeneca do? AstraZeneca PLC, listed on the stock market with ticker AZN, operates as a biopharmaceutical company focused on prescription medicines. Founded in the UK, it is headquartered in Cambridge, United Kingdom. The company develops, manufactures, and commercializes pharmaceutical products including Imjudo, Tagrisso, Imfinzi, Lynparza, Enhertu, and others. AstraZeneca's products target various therapeutic areas such as oncology, cardiovascular, respiratory, and immunology. The company went public on May 17, 1993. Its website is https://www.astrazeneca.com. AstraZeneca is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AstraZeneca stock

On Eulerpool you can find the complete historical development of Debt Service Coverage Ratio (DSCR) AstraZeneca since 2006 – with annual values, charts, and detailed analysis.

The DSCR measures a company's ability to service its debt obligations from operating income. A ratio above 1.0 indicates sufficient income to cover debt payments.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt Service Coverage Ratio (DSCR)'s AstraZeneca with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — AstraZeneca

All Key Metrics — AstraZeneca